AptarGroup (ATR) : 4 Wall Street analysts covering AptarGroup (ATR) believe that the average level the stock could reach for the short term is $80. The maximum price target given is $86 and the minimum target for short term is around $70, hence the standard deviation is calculated at $7.12.
AptarGroup (ATR) : The consensus on AptarGroup (ATR) based on 7 analyst recommendation on the company stock is 2.14, which is interpreted as a Buy recommendation. Zacks Investment Research has issued a rank of 3 which endorses a Hold on the stock. However, 3 brokers have a differing view as they consider the stock to be a Strong Buy at current levels. 4 experts consider that the stocks earnings and the quoted price is in harmony, hence, they give it a Hold rating.
AptarGroup (NYSE:ATR): The stock opened at $78.12 on Thursday but the bulls could not build on the opening and the stock topped out at $78.30 for the day. The stock traded down to $77.49 during the day, due to lack of any buying support eventually closed down at $77.97 with a loss of -0.01% for the day. The stock had closed at $77.98 on the previous day. The total traded volume was 209,862 shares.
AptarGroup, Inc. is a solution provider of a range of packaging delivery solutions for the beauty, personal care, home care, prescription drug, consumer health care, injectables, food and beverage markets. The Company has manufacturing facilities located throughout the world, including North America, Europe, Asia and South America. It offers various dispensing and sealing solutions. Its primary products are dispensing pumps, closures, aerosol valves and elastomer primary packaging components. It also manufactures and sells elastomer primary packaging components, which include stoppers for infusion, antibiotic, lyophilization and diagnostic vials. Its elastomer components also include pre-filled syringe components, such as plungers, needle shields, tip caps and cartridges, as well as dropper bulbs and disposable syringe plungers. The Companys segments include Beauty + Home, Pharma and Food + Beverage.